High-Risk Skin Cancers With Atezolizumab Plus NT-I7
NeoImmuneTech
NeoImmuneTech
Incyte Corporation
Fred Hutchinson Cancer Center
Xencor, Inc.
Nektar Therapeutics
Ludwig Institute for Cancer Research
Incyte Corporation
Fred Hutchinson Cancer Center
Incyte Corporation
Dana-Farber Cancer Institute